These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Whitehurst DG, Norman R, Brazier JE, Viney R. Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050 [Abstract] [Full Text] [Related]
6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688 [Abstract] [Full Text] [Related]
11. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F, Costs and Quality of Life in Rheumatoid Arthritis Study Group. Arthritis Rheum; 2006 Oct 15; 55(5):751-6. PubMed ID: 17013822 [Abstract] [Full Text] [Related]
12. EQ-5D versus SF-12 in coronary patients: are they interchangeable? De Smedt D, Clays E, Annemans L, De Bacquer D. Value Health; 2014 Oct 15; 17(1):84-9. PubMed ID: 24438721 [Abstract] [Full Text] [Related]
15. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study. Leung YY, Png ME, Wee HL, Thumboo J. J Rheumatol; 2013 Jun 15; 40(6):859-65. PubMed ID: 23504382 [Abstract] [Full Text] [Related]
18. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis. Tawiah AK, Al Sayah F, Ohinmaa A, Johnson JA. Health Qual Life Outcomes; 2019 Apr 17; 17(1):68. PubMed ID: 30995930 [Abstract] [Full Text] [Related]